BridgeBio PharmaBBIO
那斯達克 · USD
47.38
+0.11
(+0.23%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
BridgeBio PharmaBBIO
47.38
+0.11
(+0.23%)
財務數據
損益表
- 0.02
- 0.02
- 0.02
- 0.04
- 0.02
- 2.11
- 0.02
- 0.03
- 0.06
- 1.17
- 453.25
- -2.35
- -10.13
- 149.30
- -57.35
- 11998.57
- -98.97
- 26.01
- 115.30
- 1882.88
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 116,633 | 5,882 | 2,732 | 2,168 | 211,120 | 1,745 | 4,091 | 1,641 | 1,826 | 1,870 |
營業成本 | 2,639 | 2,084 | 598 | 598 | 598 | 598 | 598 | 599 | 651 | 647 |
營業毛利 | 113,994 | 3,798 | 2,134 | 1,570 | 210,522 | 1,147 | 3,493 | 1,042 | 1,175 | 1,223 |
營業費用 | - | - | - | - | - | 178,563 | 161,185 | 147,141 | 127,338 | 130,455 |
研發費用 | 111,431 | 130,350 | 120,444 | 114,695 | 140,972 | 130,226 | 125,136 | 107,488 | 92,861 | 90,902 |
推銷及管理費用 | 106,365 | 94,782 | 68,819 | 59,523 | 65,807 | 47,583 | 35,777 | 36,122 | 31,108 | 31,862 |
非經常性項目費用 | 570 | 4,693 | 4,621 | 2,891 | 3,400 | 754 | 272 | 3,531 | 3,369 | 7,691 |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -104,372 | -226,027 | -191,750 | -175,539 | 343 | -177,416 | -157,692 | -146,099 | -126,163 | -129,232 |
其他收入及費用 | -7,539 | 6,307 | 57,120 | 130,857 | -13,032 | 27,356 | -1,490 | 5,990 | 3,552 | 8,652 |
利息費用 | 42,141 | 29,821 | 23,061 | 22,937 | 23,471 | 20,268 | 20,306 | 20,594 | 20,121 | 19,990 |
稅前純益 | -169,608 | -266,236 | -164,254 | -75,544 | -36,160 | -170,328 | -179,488 | -160,703 | -142,732 | -140,570 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -182,978 | -281,745 | -168,603 | -81,381 | -35,216 | -168,148 | -176,999 | -157,899 | -140,156 | -137,591 |
基本每股稅後盈餘(元) | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 | -0.98 | -0.92 | -0.92 |
稀釋每股稅後盈餘(元) | -0.88 | -1.42 | -0.87 | -0.39 | -0.20 | -0.96 | -1.09 | -0.98 | -0.92 | -0.92 |
基本平均股數(千股) | 190145.00 | 189437.00 | 188510.00 | 187586.00 | 178705.00 | 174462.00 | 163308.00 | 160535.00 | 152645.00 | 149344.00 |
稀釋平均股數(千股) | 190145.00 | 189437.00 | 188510.00 | 187586.00 | 178705.00 | 174462.00 | 163308.00 | 160535.00 | 152645.00 | 149344.00 |
還原基本每股稅後盈餘(元) | -0.88 | -1.40 | -0.86 | -0.39 | -0.20 | -0.96 | -1.08 | -0.98 | -0.92 | -0.92 |
還原稀釋每股稅後盈餘(元) | -0.88 | -1.42 | -0.87 | -0.39 | -0.20 | -0.96 | -1.09 | -0.98 | -0.92 | -0.92 |
還原基本平均股數(千股) | 190,145 | 189,437 | 188,510 | 187,586 | 178,705 | 174,462 | 163,308 | 160,535 | 152,645 | 149,344 |
還原稀釋平均股數(千股) | 190,145 | 189,437 | 188,510 | 187,586 | 178,705 | 174,462 | 163,308 | 160,535 | 152,645 | 149,344 |
EBITDA(千元) | -113,912 | -240,193 | -142,288 | -55,202 | -8,134 | -144,112 | -152,910 | -133,426 | -116,064 | -113,840 |